TOKYO -- The Japanese government will spend about $1.5 billion to support the homegrown development of vaccines, Nikkei has learned, as it grapples with uncertainties from relying on imported coronavirus inoculations.
Pharmaceuticals
Japan boosts domestic vaccine industry to counter import risks
$1.5bn initiative calls for partnership with Asian nations to create clinical networks
